Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
22
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SK Telecom
•
09 Oct 2017 03:05
SK Group Restructuring - Local Institutions Are Already Making A Move
We are now seeing a very interesting move from Korea's local institutions on those SK Group restructuring stocks. Last week, to be specific from...
Sanghyun Park
Follow
356 Views
Share
bullish
•
Thematic (Sector/Industry)
•
05 Oct 2017 22:59
Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?
Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...
Sanghyun Park
Follow
1k Views
Share
bearish
•
Samsung Biologics
•
04 Oct 2017 00:25
Biosimilar Battlefield: U.S. Humira Pushed to 2023
We are updating our market model to reflect the patent litigation settlement between Amgen Inc (AMGN US) and Abbvie Inc (ABBV US) , the...
Kemp Dolliver, CFA
546 Views
Share
bullish
•
Celltrion Inc
•
28 Sep 2017 22:05
Celltrion's KOSPI Move - Seo Jung-Jin, Temasek & Price Predictions
The big day (KOSPI move decision day) is tomorrow (Sep 29) for Celltrion Inc (068270 KS). At this point, many are thinking that Celltrion's KOSPI...
Sanghyun Park
Follow
270 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Sep 2017 09:29
The Week That Was in NorthAsia@Smartkarma: Sep24
It has been another week in North Asia. North Korean missile/nuclear tests and threats? Check. Trump rhetoric on North Korea and football players?...
Travis Lundy
Follow
202 Views
Share
First
Previous
82
83
84
85
86
87
88
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.41.3
x